Your search returned 39 results.

Results
	21.	Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease. [electronic resource] by Kempf, D J Marsh, K C Paul, D A Knigge, M F Norbeck, D W Kohlbrenner, W E Codacovi, L Vasavanonda, S Bryant, P Wang, X C Producer: 19920424 In: Antimicrobial agents and chemotherapy vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. [electronic resource] by Kempf, D J Isaacson, J D King, M S Brun, S C Xu, Y Real, K Bernstein, B M Japour, A J Sun, E Rode, R A Producer: 20010823 In: Journal of virology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	23.	ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. [electronic resource] by Kempf, D J Marsh, K C Denissen, J F McDonald, E Vasavanonda, S Flentge, C A Green, B E Fino, L Park, C H Kong, X P Producer: 19950511 In: Proceedings of the National Academy of Sciences of the United States of America vol. 92 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	24.	Structure-based, C2 symmetric inhibitors of HIV protease. [electronic resource] by Kempf, D J Norbeck, D W Codacovi, L Wang, X C Kohlbrenner, W E Wideburg, N E Paul, D A Knigge, M F Vasavanonda, S Craig-Kennard, A Producer: 19901120 In: Journal of medicinal chemistry vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	25.	The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir. [electronic resource] by Kempf, D J Rode, R A Xu, Y Sun, E Heath-Chiozzi, M E Valdes, J Japour, A J Danner, S Boucher, C Molla, A Leonard, J M Producer: 19980608 In: AIDS (London, England) vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	26.	Potent HIV-1 protease inhibitors with antiviral activities in vitro. [electronic resource] by Sham, H L Betebenner, D A Wideburg, N E Saldivar, A C Kohlbrenner, W E Vasavanonda, S Kempf, D J Norbeck, D W Zhao, C Clement, J J Producer: 19910605 In: Biochemical and biophysical research communications vol. 175 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	27.	Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. [electronic resource] by Kaplan, A H Michael, S F Wehbie, R S Knigge, M F Paul, D A Everitt, L Kempf, D J Norbeck, D W Erickson, J W Swanstrom, R Producer: 19940706 In: Proceedings of the National Academy of Sciences of the United States of America vol. 91 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	28.	Pseudo-symmetrical difluoroketones. Highly potent and specific inhibitors of HIV-1 protease. [electronic resource] by Sham, H L Betebenner, D A Wideburg, N Saldivar, A C Kohlbrenner, W E Craig-Kennard, A Vasavanonda, S Kempf, D J Clement, J J Erickson, J E Producer: 19930921 In: FEBS letters vol. 329 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	29.	Potent, low molecular weight renin inhibitors containing a C-terminal heterocycle: hydrogen bonding at the active site. [electronic resource] by Rosenberg, S H Dellaria, J F Kempf, D J Hutchins, C W Woods, K W Maki, R G de Lara, E Spina, K P Stein, H H Cohen, J Producer: 19900628 In: Journal of medicinal chemistry vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	30.	In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification. [electronic resource] by Kumar, G N Jayanti, V Lee, R D Whittern, D N Uchic, J Thomas, S Johnson, P Grabowski, B Sham, H Betebenner, D Kempf, D J Denissen, J F Producer: 19990301 In: Drug metabolism and disposition: the biological fate of chemicals vol. 27 Availability: No items available. Save to lists Add to cart (remove)
	31.	Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus. [electronic resource] by Molla, A Vasavanonda, S Kumar, G Sham, H L Johnson, M Grabowski, B Denissen, J F Kohlbrenner, W Plattner, J J Leonard, J M Norbeck, D W Kempf, D J Producer: 19981217 In: Virology vol. 250 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	32.	Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. [electronic resource] by Chen, X Kempf, D J Sham, H L Green, B E Molla, A Korneyeva, M Vasavanonda, S Wideburg, N E Saldivar, A Marsh, K C McDonald, E Norbeck, D W Producer: 19990405 In: Bioorganic & medicinal chemistry letters vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	33.	NMR-based discovery of lead inhibitors that block DNA binding of the human papillomavirus E2 protein. [electronic resource] by Hajduk, P J Dinges, J Miknis, G F Merlock, M Middleton, T Kempf, D J Egan, D A Walter, K A Robins, T S Shuker, S B Holzman, T F Fesik, S W Producer: 19971110 In: Journal of medicinal chemistry vol. 40 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	34.	Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. [electronic resource] by Kempf, D J Marsh, K C Kumar, G Rodrigues, A D Denissen, J F McDonald, E Kukulka, M J Hsu, A Granneman, G R Baroldi, P A Sun, E Pizzuti, D Plattner, J J Norbeck, D W Leonard, J M Producer: 19970602 In: Antimicrobial agents and chemotherapy vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	35.	Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. [electronic resource] by Molla, A Korneyeva, M Gao, Q Vasavanonda, S Schipper, P J Mo, H M Markowitz, M Chernyavskiy, T Niu, P Lyons, N Hsu, A Granneman, G R Ho, D D Boucher, C A Leonard, J M Norbeck, D W Kempf, D J Producer: 19960813 In: Nature medicine vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	36.	Ritonavir and saquinavir combination therapy for the treatment of HIV infection. [electronic resource] by Cameron, D W Japour, A J Xu, Y Hsu, A Mellors, J Farthing, C Cohen, C Poretz, D Markowitz, M Follansbee, S Angel, J B McMahon, D Ho, D Devanarayan, V Rode, R Salgo, M Kempf, D J Granneman, R Leonard, J M Sun, E Producer: 19990528 In: AIDS (London, England) vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	37.	Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. [electronic resource] by Kempf, D J Sham, H L Marsh, K C Flentge, C A Betebenner, D Green, B E McDonald, E Vasavanonda, S Saldivar, A Wideburg, N E Kati, W M Ruiz, L Zhao, C Fino, L Patterson, J Molla, A Plattner, J J Norbeck, D W Producer: 19980317 In: Journal of medicinal chemistry vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	38.	A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease. [electronic resource] by Sham, H L Zhao, C Stewart, K D Betebenner, D A Lin, S Park, C H Kong, X P Rosenbrook, W Herrin, T Madigan, D Vasavanonda, S Lyons, N Molla, A Saldivar, A Marsh, K C McDonald, E Wideburg, N E Denissen, J F Robins, T Kempf, D J Plattner, J J Norbeck, D W Producer: 19960228 In: Journal of medicinal chemistry vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	39.	ABT-378, a highly potent inhibitor of the human immunodeficiency virus protease. [electronic resource] by Sham, H L Kempf, D J Molla, A Marsh, K C Kumar, G N Chen, C M Kati, W Stewart, K Lal, R Hsu, A Betebenner, D Korneyeva, M Vasavanonda, S McDonald, E Saldivar, A Wideburg, N Chen, X Niu, P Park, C Jayanti, V Grabowski, B Granneman, G R Sun, E Japour, A J Leonard, J M Plattner, J J Norbeck, D W Producer: 19990222 In: Antimicrobial agents and chemotherapy vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)